Today: 30 January 2026
Subscribe
Browse Category

Stock Analysis News 24 September 2025 - 4 October 2025

Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Key facts (as of Oct 4, 2025) CEO Subodh Kulkarni: “Our industry‑leading chiplet approach to scaling and strong financial position makes us confident in hitting our end‑of‑year technology goals.” GlobeNewswire What Rigetti does—at a glance Rigetti is a full‑stack, superconducting, gate‑based quantum‑computing company. It manufactures chips in‑house (Fab‑1), exposes systems via its cloud and major clouds (AWS/Azure), and now sells…
4 October 2025
····
Quantum Computing Inc (QUBT) Stock Skyrockets on $500M Fundraising and New Tech Debut – Can the Rally Last?

Quantum Computing Inc (QUBT) Soars 24% on $500M Funding & New “Quantum Secure” Tech – Will It Hit $40?

Recent Performance and Financials Quantum Computing Inc (Nasdaq: QUBT) has a multi-billion-dollar market cap (share count ~185M after the placement), driven by the funding and product buzz. On Oct 2 it closed $19.98 (Nasdaq) Stoculator. Year-to-date through early October 2025 it is up ~54% Finviz (versus double-digit gains for peers like Rigetti, IonQ, D-Wave Fastcompany). However, QCi’s fundamentals remain speculative. Q2…
3 October 2025
····
Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Stock Performance (Oct 3, 2025) As of this afternoon’s trading on Oct 3, Oscar Health shares are up ~2.8% around $19.81. The stock opened near $19.82 and is trading in a tight range (today’s low ~$19.80, high ~$19.95). Yesterday (Oct 2) it closed at $19.28 (+2.0%), continuing a rebound from late-September lows (it had hit ~$17 in mid-September). Volume so…
3 October 2025
·····
Sarepta Therapeutics (SRPT) Surges After FDA Greenlights Duchenne Gene Therapy – Is a Rebound Ahead?

Sarepta Therapeutics (SRPT) Surges After FDA Greenlights Duchenne Gene Therapy – Is a Rebound Ahead?

Stock Performance and Trends Sarepta’s stock is recovering some ground after steep losses. As of Oct 2, 2025, SRPT closed at $19.57, up about 6.8%for the day Investing. This followed a general uptrend in recent weeks: SRPT is up roughly 16% over the last month Marketbeat (though still down >80% from early 2025 levels). Trading volume has been moderate (0.6 million on Oct 2 vs.…
2 October 2025
····
Saudi Aramco Stock Analysis 2025: Is the Oil Giant Still Worth Your Money?

Saudi Aramco Stock Analysis 2025: Is the Oil Giant Still Worth Your Money?

2025 YTD Stock Performance Saudi Aramco’s stock (Tadawul: 2222.SR) started 2025 in the SR 22 range and rose above SR 24 by late September, giving a year‑to‑date gain of roughly 12 % Argaam. FinanceCharts data show the share price closing at SR 24.62 on 30 September, down 1.48 % from the previous day but up 3.45 % over the past 30 days Financecharts. Over the last twelve months the…
1 October 2025
····
Apple Stock Outlook 2025: iPhone 17 Buzz, AI Push, and What’s Next for AAPL

Apple Stock Outlook 2025: iPhone 17 Buzz, AI Push, and What’s Next for AAPL

Apple’s 2025 Performance and Q4 Outlook Apple’s stock has had a choppy year. After a selloff in early 2025, the shares rebounded following strong Q3 results in July. Fiscal Q3 (ending June 28) revenue was $94.0 billion (up ~10% YoY) with EPS $1.57, topping consensus Reuters. All major segments grew: iPhone sales jumped 13.5% (to $44.6 B) Reuters, Mac sales beat expectations,…
1 October 2025
····
DTE Energy (NYSE:DTE) Stock Set to Surge? Analysts Highlight Smart-Grid Wins and AI-Driven Demand

DTE Energy (NYSE:DTE) Stock Set to Surge? Analysts Highlight Smart-Grid Wins and AI-Driven Demand

Stock Performance and Analyst Consensus DTE Energy’s stock has been relatively stable and is trading near its annual highs. On Sept. 26, 2025 the stock closed around $139.36 Marketbeat. According to MarketBeat, that day’s close was up +1.23%. The shares have a 52-week trading range of roughly $115.59 to $142.05 Stockanalysis, so current prices are only a few dollars below…
29 September 2025
····
Scholar Rock (SRRK) Just Hit a Regulatory Speed Bump—But the Long‑Term Muscle‑Building Story Still Has Legs

Scholar Rock (SRRK) Just Hit a Regulatory Speed Bump—But the Long‑Term Muscle‑Building Story Still Has Legs

Key facts (as of September 26, 2025) What happened this week (Sept. 23–26) Company snapshot & pipeline Scholar Rock is a late‑stage biotech developing apitegromab, a selective antibody that blocks latent myostatin activation to build/maintain skeletal muscle. Pipeline also includes SRK‑181 (anti‑latent TGF‑β1, oncology; Phase 1) and SRK‑439 (next‑gen anti‑latent myostatin; IND planned for 2H25).  Scholar Rock The SMA evidence base: apitegromab’s pivotal data The obesity tie‑in: preserving muscle…
26 September 2025
···
RIG Stock Meltdown: Transocean’s $381M Share Sale Rocks the Market—Will 13% Dilution Fix the Debt Problem or Set Up a Rebound?

RIG Stock Meltdown: Transocean’s $381M Share Sale Rocks the Market—Will 13% Dilution Fix the Debt Problem or Set Up a Rebound?

Key facts (Sept. 25–26, 2025) What just happened—and why it mattered Timeline (Sept. 24–26): Strategic aim: Management is steering fresh equity toward debt reduction, specifically highlighting the 8.00% notes due 2027. If all base proceeds went against those notes, annual interest expense could fall by ~$30.5M (and ~$35M with a fully exercised green‑shoe), before fees and taxes. The greenshoe option…
26 September 2025
····
European Markets Whiplash: Defense Stocks Soar as Luxury Lags in 48-Hour Rollercoaster

European Markets Whiplash: Defense Stocks Soar as Luxury Lags in 48-Hour Rollercoaster

Key Facts European Stock Indices: Two Days of Turbulence Major indexes in Europe seesawed between gains and losses over the two-day span, reacting to a flurry of news. On Wednesday Sept. 24, the broad STOXX Europe 600 slipped -0.2% by the close Reuters. Regionally, performance was mixed – the UK’s FTSE 100 actually rose +0.3% (outperforming peers), and Germany’s DAX…
25 September 2025
···
Southern Copper (SCCO) Skyrockets on Copper Price Boom – Key Facts & Outlook

Southern Copper (SCCO) Skyrockets on Copper Price Boom – Key Facts & Outlook

Southern Copper Corporation Overview and Market Outlook as of September 24, 2025 SCCO Stock Performance in Late September 2025 Southern Copper’s stock has been on a tear in recent weeks, climaxing with a sharp rally around September 24, 2025. On that day, SCCO surged roughly 8–9%, hitting a new 52-week high of about $117–$121 per share Investing Ainvest. This jump…
24 September 2025
···
1 … 65 66 67

Stock Market Today

  • Jade Road Investments Announces $8.6 Million Equity Subscription and New Fundraising Plans
    January 30, 2026, 2:59 AM EST. Jade Road Investments has secured $8.6 million (approximately £6.3 million) in a preliminary equity fundraising by issuing shares at $1 each. Completion is expected by February 6, 2026, to comply with AIM Rules requiring at least £6 million raised from independent investors. Trading remains suspended until then. The company appointed NOIA Capital (DIFC) Limited exclusively to manage this and a planned larger fundraising phase targeting between $100 million and $150 million. NOIA will also receive shares equivalent to 5% of the fully diluted share capital following the fundraising rounds as payment for their services. The move aims to finance Jade's investment strategy, though there is no guaranteed completion for the larger fundraising phase.
Go toTop